Primary FDA-Approved Indications
Only FDA-approved therapy for pediatric cryptosporidiosis and widely used for giardiasis.
Cryptosporidiosis
FDA ApprovedChildren 1-11 yearsRandomized trials
Evidence Sources
()
Giardiasis
FDA ApprovedChildrenRandomized trials
Evidence Sources
()